Stock Updates

Merck & Co., Inc. (NYSE: MRK) – Is this large market cap stock undervalued?

Merck & Co., Inc. (NYSE: MRK), is firmly in the large market cap category with market cap of 172493.8. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Merck & Co., Inc. is 61.72 (with a change from open of -0.89%), this in conjunction with a target price of 65.47. Volume today has so far reached 3439858, with an average volume of about 9988.44. The GAP for this stock, is 0.00%.

The P/E ratio is 34.11, bringing the forward P/E to a value of 16.15. The current EPS for Merck & Co., Inc., is 1.83, with a EPS growth for this year coming to a value of -61.60%. Performance has been interesting with performance year to date coming to 20.79%.

Looking further into the growth statistics for Merck & Co., Inc., EPS is looking like it will grow 2.85% in the next year. Looking even further it is projected to be 6.27%. Quarter over quarter is 79.20% for EPS growth and for sales growth quarter over quarter it is 0.60%. Looking at past EPS growth statistics we see that for the past five years it has been 41.50%. Sales growth for the past five years has in fact been -3.00%.

Looking at the ownership, we see that the insider ownership is at 0.04% and institutional ownership is 75.00%. Shares outstanding is 2769.65, while shares float is at a value of 2764.14. Float short for Merck & Co., Inc. is 1.09% and the short ratio is 3.

In terms of debt, long term debt/equity is 0.55, while the total debt/equity comes to 0.56. The ability to meet these debts, means that the current ratio is 1.9, and the quick ratio is 1.5. The most recent gross margin is 63.20% and their operating margin is 18.10%. The profit margin is 13.00%.

Merck & Co., Inc. has seen returns on assets of 5.20%, and on investment, 6.40%. Return on equity is 11.60%. Price/Earnings to growth ratio is 5.44. Price/Sales ratio is at a value of 4.37, with Price/book ratio coming to 3.98 and Price/cash is 14.58, and finally Price/Free cash Flow is 36.33.

The simple moving averages are 1.40% and 12.83% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -2.85% and the 52 week low is 32.63%.

Merck & Co., Inc. has a dividend yield of 2.95%, with a current price of 61.72. The ability to pay this means the payout ratio is 99.50%. This is in an industry, Drug Manufacturers – Major, with equally high dividends from other companies in this sector, which it is Healthcare. Merck & Co., Inc. is based in USA.

Performance in the Drug Manufacturers – Major industry means that Merck & Co., Inc. has seen performance for the past week of 0.39%, with performance for the month coming to -0.87%. Looking at the data for the quarter it is at a value of 12.25%, and for the half year the performance is 19.26%. Volatility for this week is 1.98% and for the month this is 1.32%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment